Kukamonga

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• NO ENGLISH1 refused line

  Required label information not in English

  Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.

Questions about Kukamonga

Is Kukamonga on an FDA import alert?

Yes. As of October 26, 2026, Kukamonga is on the red list of FDA Import Alert 54-16, “Foods/supplements with active pharmaceutical ingredient”, for kuka flex cbd 100 mg (glucosamine flex green chondroitin hyaluronic acid msm green flex); FDA published the listing on August 14, 2026.

Has FDA refused shipments from Kukamonga?

Yes. FDA refused 1 shipment line from Kukamonga on July 10, 2024. The most recent, on July 10, 2024, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as NO ENGLISH (required label information not in english).

Why did FDA refuse Kukamonga's shipments?

The most frequent charge is NO ENGLISH (required label information not in english, 1 line).

What is Kukamonga's FEI number?

Kukamonga's FDA Establishment Identifier (FEI) is 3015859325.

Can shipments from Kukamonga still enter the U.S.?

Shipments of kuka flex cbd 100 mg (glucosamine flex green chondroitin hyaluronic acid msm green flex) from Kukamonga can be detained without physical examination under Import Alert 54-16; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).